LINCOLN
Invest Now
Start SIP in
LINCOLN
Performance
- Low
- ₹598
- High
- ₹609
- 52 Week Low
- ₹499
- 52 Week High
- ₹980
- Open Price₹601
- Previous Close₹599
- Volume51,218
Investment Returns
- Over 1 Month + 6.69%
- Over 3 Month + 6.8%
- Over 6 Month -1.81%
- Over 1 Year + 4.69%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13.5
- PEG Ratio
- 5.6
- Market Cap Cr
- 1,208
- P/B Ratio
- 1.9
- Average True Range
- 20.55
- EPS
- 44.62
- Dividend Yield
- 0.3
- MACD Signal
- 3.38
- RSI
- 60.82
- MFI
- 68.77
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹603.15
+
3.7
(0.62%)

-
- Bearish Moving Average 5
-
- Bullish Moving Average 11
- 20 Day
- ₹579.53
- 50 Day
- ₹585.57
- 100 Day
- ₹616.57
- 200 Day
- ₹637.97
Resistance and Support
603.37
- R3 621.03
- R2 615.22
- R1 609.18
- S1 597.33
- S2 591.52
- S3 585.48
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-22 | Audited Results & Final Dividend | |
2025-02-13 | Quarterly Results | |
2024-11-14 | Quarterly Results | |
2024-08-08 | Quarterly Results | |
2024-05-16 | Audited Results & Final Dividend |
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹603 As on 19 May, 2025 | 22:37
The Market Cap of Lincoln Pharmaceuticals is ₹1208.1 Cr As on 19 May, 2025 | 22:37
The P/E ratio of Lincoln Pharmaceuticals is 13.5 As on 19 May, 2025 | 22:37
The PB ratio of Lincoln Pharmaceuticals is 1.9 As on 19 May, 2025 | 22:37
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.